A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John L Marshall, MD
Chief, Division of Hematology/Oncology, Georgetown University Hospital Washington
Principal Investigator - Ramon Salazar, MD
Institut Català D´Oncologia, L'Hospitalet Barcelona
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Landeskrankenhaus Feldkirch
Feldkirch, Austria
- Krankenhaus Der Elisabethinen
Linz, Austria
- Medical University of Vienna
Vienna, Austria
- University of Hong Kong/ Queen Mary Hospital
Hong Kong, China
- Odense Universitetshospital
Odense, Denmark
- Crlc Val D'Aurelle-Paul Lamarque
Montpellier, France
- Klinikum Rechts Der Isar
Munich, Germany
- Matsuda Hospital
Hamamatsu, Japan
- Medisch Centrum Alkmaar
Alkmaar, Netherlands
- Medisch Spectrum Twente
Enschede, Netherlands
- Westfriesgasthuis
Hoorn, Netherlands
- Lumc
Leiden, Netherlands
- Vall D' Hebron University Hospital
Barcelona, Spain
- Idibell Institut Catala D'Oncologia (ico)
L'Hospitalet de Llobregat, Spain
- Immunology Akademiska Sjukhuset/ University Hospital
Uppsala, Sweden
- Kantonsspital Baden
Baden, Switzerland
- Norfolk and Norwich University Hospital
Norwich, United Kingdom
- University of Oxford
Oxford, United Kingdom
- Glendale Memorial Hospital
Glendale, California, United States
- South Orange County Surgical Medical Group
Laguna Hills, California, United States
- Long Beach Memorial Medical Center
Long Beach, California, United States
- Sutter Roseville Medical Center /research
Roseville, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Uc Davis Cancer Center
Sacramento, California, United States
- Scripps Cancer Center
San Diego, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Georgetown University Hospital
Washington D.C., District of Columbia, United States
- University of Miami
Miami, Florida, United States
- Atlanta Colon and Rectal Surgery
Riverdale, Georgia, United States
- Albert Einstein College of Medicine, Montefiore Medical Center
The Bronx, New York, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Franciscan Research Center
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 31 Dec 2019
- Completion
- 31 Dec 2019
- Last update posted
- 9 Jan 2019
- Registered enrollment
- 1,200
- Registry id
- NCT00903565
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.